Insider track record Other Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Dr Hal Barron. Director active across 1 company, notably GSK plc. In total, 66 reports have been logged. Activity tracked since 20 June 2023. The latest transaction was disclosed on 10 July 2026 (Purchase). Regulator: RNS (LSE). The full history is openly available.
Companies and markets linked to Dr Hal Barron Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 66 total
● Non-Executive Director · Executives · 10 Jul 2026 · GSK plc 28 shares @ £52.7354 ISIN ISIN US37733W2044RNS:9673287-6 ● Non-Executive Director · Executives · 10 Jul 2026 · GSK plc 28 shares @ £0.5275 0.0000% mcap 0.0% of flow ISIN ISIN US37733W2044RNS:68763dee-a518-4ccc-8d25-48330cbfa37e-6 ● Non-Executive Director · Executives · 15 May 2026 · GSK plc 74 shares @ £0.4968 0.0000% mcap 0.1% of flow ISIN ISIN US37733W2044RNS:71bad38c-0929-4edd-b15e-28516b69c2b2 ● Non-Executive Director · Executives · 15 May 2026 · GSK plc 74 shares @ £49.67 0.0000% mcap 100.0% of flow ISIN ISIN US37733W2044RNS:9578478 ● Non-Executive Director · Executives · 9 Apr 2026 · GSK plc 26 shares @ £0.5892 0.0000% mcap 0.0% of flow ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-12 ● Non-Executive Director · Executives · 20 Feb 2026 · GSK plc 64 shares @ £0.5952 0.1% of flow ISIN ISIN US37733W2044RNS:1775c9bd-4348-4ec9-b09c-470ab0585b57 ● Non-Executive Director · Executives · 14 Jan 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:2a8cdbd4-1f4a-4a5f-a33e-d0463dade4dc-0 ● Non-Executive Director · Executives · 9 Jan 2026 · GSK plc 28 shares @ £0.5043 0.0% of flow ISIN ISIN US37733W2044RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-36 ● Non-Executive Director · Executives · 14 Nov 2025 · GSK plc 69 shares @ £0.4717 0.1% of flow ISIN ISIN US37733W2044RNS:32cbdf7b-559f-4c56-829b-a5f4769c98f9-1 ● Non-Executive Director · Executives · 14 Oct 2025 · GSK plc 0
ISIN ISIN US37733W2044RNS:5864301-0 ● Non-Executive Director · Executives · 10 Oct 2025 · GSK plc 28 shares @ £0.4375 0.0% of flow ISIN ISIN US37733W2044RNS:5859068-27 ● Non-Executive Director · Executives · 19 Sept 2025 · GSK plc 240 shares @ £0.4074 0.3% of flow ISIN ISIN US37733W2044RNS:5830475-3 ● Non-Executive Director · Executives · 15 Aug 2025 · GSK plc 84 shares @ £0.3936 0.1% of flow ISIN ISIN US37733W2044RNS:5786546-1 ● Non-Executive Director · Executives · 17 Jul 2025 · GSK plc 0
ISIN ISIN US37733W2044RNS:5744703-0 ● Non-Executive Director · Executives · 11 Jul 2025 · GSK plc 30 shares @ £0.3853 0.0% of flow ISIN ISIN US37733W2044RNS:5737340-34 ● Non-Executive Director · Executives · 20 Jun 2025 · GSK plc 258 shares @ £0.379 0.3% of flow ISIN ISIN US37733W2044RNS:5708028-4 ● Non-Executive Director · Executives · 20 Jun 2025 · GSK plc 258 shares @ £0.379 0.3% of flow ISIN ISIN US37733W2044RNS:5707630-4 ● Non-Executive Director · Executives · 16 May 2025 · GSK plc 87 shares @ £0.3764 0.1% of flow ISIN ISIN US37733W2044RNS:5661771-1 ● Non-Executive Director · Executives · 15 Apr 2025 · GSK plc 0
ISIN ISIN US37733W2044RNS:5622701-13 ● Non-Executive Director · Executives · 11 Apr 2025 · GSK plc 29 shares @ £0.3414 0.0% of flow ISIN ISIN US37733W2044RNS:5617047-2 ● Non-Executive Director · Executives · 20 Mar 2025 · GSK plc 249 shares @ £0.3927 0.3% of flow ISIN ISIN US37733W2044RNS:5584787-4 ● Non-Executive Director · Executives · 21 Feb 2025 · GSK plc 83 shares @ £0.3664 0.1% of flow ISIN ISIN US37733W2044RNS:5553317-1 ● Non-Executive Director · Executives · 18 Feb 2025 · GSK plc 45,690 shares 0
ISIN ISIN US37733W2044RNS:5546603-2 ● Non-Executive Director · Executives · 18 Feb 2025 · GSK plc 24,623 shares @ £0.3664 26.5% of flow ISIN ISIN US37733W2044RNS:5546603-3 ● Non-Executive Director · Executives · 14 Jan 2025 · GSK plc 0
ISIN ISIN US37733W2044RNS:5502203-14 25 of 66 declarations
Load more (41 remaining) About Dr Hal Barron Dr Hal Barron has filed 64 declarations in total. As Non-Executive Director of GSK plc, his 64 sampled filings, covering the period from 2023-06-23 to 2026-05-20, show purchases of EUR 5941 and sales of EUR 34332, with the modal transaction nature listed as Purchase.